Brendan Kennedy, CEO of medical cannabis producer Tilray, poses in a greenhouse of the Canadian company’s European production site in Cantanhede on April 24, 2018.
Patricia De Melo Moreira | AFP | Getty Images
Brendan Kennedy, CEO of Canadian cannabis company Tilray, is optimistic that the US will take steps to federally legalize marijuana in the near future, which will shake the industry forever.
“I assume that the pressure from the north and the south will eventually cause the US to implement a federal program here sometime in the next 18 to 24 months,” said Kennedy in an interview on CNBC’s “Squawk on the Street” on Wednesday.
Mexico released regulations on medical cannabis use earlier this month, and Kennedy is confident that Mexico and Canada’s positive stance on marijuana will put more pressure on the US
Tilray announced Tuesday that it had been selected by the country’s National Agency for the Safety of Medicines and Health Products to be the supplier of medical cannabis for experiments in France.
The company has been selling its cannabis products in Germany since 2017. With the French program launched in the first quarter, Kennedy is optimistic that other European countries will run medical marijuana programs as well.
“While we are excited about our opportunities in Germany and France, we expect additional opportunities for our European companies in the coming quarters,” said Kennedy in an interview with CNBC.
Tilray has licenses to produce cannabis in Canada and Portugal, where the main cannabis facility is located.